GlassScriptPhysician profile
Arturo Lopez
NPI 1932137882
$9,472.16
in general payments reported to CMS, 2019-2025
47 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $1,110 · 2021: $1,288 · 2022: $1,684 · 2023: $1,386 · 2024: $1,593 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,273 · Education: $73.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,273.48 |
| Education | $73.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,558.03 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Actelion Pharmaceuticals US, INC. | $1,555.08 | 2019-2025 | Uptravi, Opsumit |
| Abiomed | $774.73 | 2022-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $737.85 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $674.88 | 2019-2025 | Breztri, Airsupra, Fasenra |
| United Therapeutics Corporation | $403.57 | 2020-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $349.49 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $308.36 | 2019-2023 | Yupelri |
| Janssen Pharmaceuticals, INC | $272.86 | 2021-2022 | |
| Insmed, INC. | $188.80 | 2022-2025 | Arikayce |
| Pulmonx Corporation | $180.86 | 2022-2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Gilead Sciences, INC. | $167.04 | 2019-2023 | Veklury |
| Merck Sharp & Dohme LLC | $145.11 | 2022-2025 | Winrevair |
| Ambu INC. | $141.68 | 2022-2023 | |
| Abbvie INC. | $133.78 | 2022-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $131.11 | 2021-2025 | |
| Philips North America LLC | $125.74 | 2020-2024 | (2383) Sleepundivided, (Ak6) Vest Therapy |
| Inari Medical, INC. | $122.84 | 2022 | |
| Fisher & Paykel Healthcare INC | $116.78 | 2021-2025 | Fisher & Paykel Healthcare |
| Mallinckrodt Hospital Products INC. | $106.65 | 2024-2025 | Acthar, Terlivaz |
| Ekos Corporation | $97.63 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.19 | 2020-2024 | Glassia |
| Boston Scientific Corporation | $84.88 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $79.62 | 2023-2024 | |
| Tactile Systems Technology INC | $73.75 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Travere Therapeutics, INC. | $73.72 | 2024 | |
| Lilly USA, LLC | $68.25 | 2024-2025 | Jardiance |
| Resmed Corp | $60.96 | 2023 | |
| Veloxis Pharmaceuticals, INC. | $57.38 | 2025 | Envarsus |
| Baxter Healthcare | $56.53 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $56.15 | 2021 | |
| Electromed, INC. | $49.45 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $42.64 | 2019-2025 | Dupixent |
| Amgen INC. | $40.08 | 2022-2024 | Tavneos |
| Advanced Respiratory, INC | $39.70 | 2020-2021 | |
| Shire North American Group INC | $33.89 | 2019 | |
| Genentech USA, INC. | $33.57 | 2019 | |
| Circassia INC. | $31.96 | 2019 | |
| Sunovion Pharmaceuticals INC. | $29.37 | 2019 | |
| One Lambda, INC. | $25.82 | 2024 | |
| Verona Pharma, INC. | $24.96 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $24.52 | 2023 | Inspire |
| Teva Pharmaceuticals USA, INC. | $21.23 | 2022 | |
| La Jolla Pharmaceutical Company | $20.83 | 2019 | |
| Edwards Lifesciences Corporation | $19.99 | 2019 | |
| Pfizer INC. | $18.91 | 2022 | |
| Harmony Biosciences LLC | $16.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.